FDA Inspection
StimLabs, LLCStimLabs, LLC – FDA Inspection, Apr 7, 2022
Record Details
This FDA Inspection record concerns StimLabs, LLC, with an inspection on April 7, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- StimLabs, LLC
- Inspection Date
- April 7, 2022
- Product Type
- Biologics
View Company Profile
ID · f1f9b7ff-d9b9-41a7-ae84-e4d1d16784bc
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1167413
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of StimLabs, LLC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 6, 2026 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| January 2, 2018 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for StimLabs, LLC
- FDA Inspection 1330752 - 2026-08-06
- FDA Inspection 1038774 - 2018-01-02
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.